Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Sallevelt, Bastiaan"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anrys, Pauline, Petit, Anne-Elisabeth, Thevelin, Stefanie, Sallevelt, Bastiaan, Drenth, Clara, Soiza, Roy L., Correa-Pérez, Andrea, Dalleur, Olivia, De Brauwer, Isabelle, Petrovic, Mirko, Coleman, Jamie J., Dalton, Kieran, O'Mahony, Denis, Löwe, Axel, Thürig, Silvan, Gudmundsson, Aðalsteinn, Cherubini, Antonio, Panos, Agapios, Mavridis, Dimitris, Rodondi, Nicolas, Spinewine, Anne
Publikováno v:
In Journal of the American Medical Directors Association October 2021 22(10):2121-2133
Autor:
Huibers, Corlina J.A., Sallevelt, Bastiaan T.G.M., de Groot, Dominique A., Boer, Maarten J., van Campen, Jos P.C.M., Davids, Cathelijn J., Hugtenburg, Jacqueline G., Vermeulen Windsant-Van den Tweel, Annemieke M.A., van Hout, Hein P.J., van Marum, Rob J., Meulendijk, Michiel C.
Publikováno v:
In International Journal of Medical Informatics May 2019 125:110-117
Autor:
Schalbetter, Fabian, Jungo, Katharina Tabea, Deml, Michael J., Moor, Jeanne, Feller, Martin, Lüthold, Renata Vidonscky, Alida Huibers, Corlina Johanna, Marie Sallevelt, Bastiaan Theodoor Gerard, Meulendijk, Michiel C., Spruit, Marco, Schwenkglenks, Matthias, Rodondi, Nicolas, Streit, Sven
Publikováno v:
BMC Health Services Research; 3/18/2024, Vol. 24, p1-11, 11p, 1 Diagram, 2 Charts
Autor:
Noorda, Nikki M.F., Sallevelt, Bastiaan T.G.M., Langendijk, Wivien L., Egberts, Toine C.G., van Puijenbroek, Eugène P., Wilting, Ingeborg, Knol, Wilma, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
European Geriatric Medicine, 13(4), 837. Elsevier Masson SAS
European Geriatric Medicine, 13. Springer
European Geriatric Medicine, 13. Springer
Key summary pointsAim To investigate the performance of an adverse drug reaction (ADR) trigger tool in patients with polypharmacy acutely admitted to our geriatric ward. Findings The ADR trigger tool had a positive predictive value (PPV) of 41.8%. Us
Autor:
Sallevelt, Bastiaan T G M, Huibers, Corlina J A, Heij, Jody M J Op, Egberts, Toine C G, van Puijenbroek, Eugène P, Shen, Zhengru, Spruit, Marco R, Jungo, Katharina Tabea, Rodondi, Nicolas, Dalleur, Olivia, Spinewine, Anne, Jennings, Emma, O'Mahony, Denis, Wilting, Ingeborg, Knol, Wilma, Afd Pharmacoepi & Clinical Pharmacology, Sub Natural Language Processing, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Drugs & Aging
Drugs and Aging, 39, 59-73. ADIS INT LTD
Sallevelt, Bastiaan T G M; Huibers, Corlina J A; Heij, Jody M J Op; Egberts, Toine C G; van Puijenbroek, Eugène P; Shen, Zhengru; Spruit, Marco R; Jungo, Katharina Tabea; Rodondi, Nicolas; Dalleur, Olivia; Spinewine, Anne; Jennings, Emma; O'Mahony, Denis; Wilting, Ingeborg; Knol, Wilma (2022). Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity. Drugs & aging, 39(1), pp. 59-73. Adis International 10.1007/s40266-021-00904-z
Drugs & Aging, 39(1), 59-73. ADIS INT LTD
Drugs & Aging, 39(1), 59. NLM (Medline)
Drugs and Aging, 39, 59-73. ADIS INT LTD
Sallevelt, Bastiaan T G M; Huibers, Corlina J A; Heij, Jody M J Op; Egberts, Toine C G; van Puijenbroek, Eugène P; Shen, Zhengru; Spruit, Marco R; Jungo, Katharina Tabea; Rodondi, Nicolas; Dalleur, Olivia; Spinewine, Anne; Jennings, Emma; O'Mahony, Denis; Wilting, Ingeborg; Knol, Wilma (2022). Frequency and Acceptance of Clinical Decision Support System-Generated STOPP/START Signals for Hospitalised Older Patients with Polypharmacy and Multimorbidity. Drugs & aging, 39(1), pp. 59-73. Adis International 10.1007/s40266-021-00904-z
Drugs & Aging, 39(1), 59-73. ADIS INT LTD
Drugs & Aging, 39(1), 59. NLM (Medline)
Background The Screening Tool of Older Persons’ Prescriptions (STOPP)/Screening Tool to Alert to Right Treatment (START) instrument is used to evaluate the appropriateness of medication in older people. STOPP/START criteria have been converted into
Autor:
Sallevelt, Bastiaan T.G.M., Egberts, Toine C.G., Huibers, Corlina J.A., Ietswaart, Jimmy, Drenth-van Maanen, A. Clara, Jennings, Emma, O’Mahony, Cian, Jungo, Katharina Tabea, Feller, Martin, Rodondi, Nicolas, Sibille, François Xavier, Spinewine, Anne, van Puijenbroek, Eugène P., Wilting, Ingeborg, Knol, Wilma, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Sallevelt, Bastiaan T G M; Egberts, Toine C G; Huibers, Corlina J A; Ietswaart, Jimmy; Drenth-van Maanen, A Clara; Jennings, Emma; O'Mahony, Cian; Jungo, Katharina Tabea; Feller, Martin; Rodondi, Nicolas; Sibille, François-Xavier; Spinewine, Anne; van Puijenbroek, Eugène P; Wilting, Ingeborg; Knol, Wilma (2022). Detectability of Medication Errors With a STOPP/START-Based Medication Review in Older People Prior to a Potentially Preventable Drug-Related Hospital Admission. Drug safety, 45(12), pp. 1501-1516. Springer 10.1007/s40264-022-01237-5
Drug Safety, Vol. 45, no. 12, p. 1501-1516 (2022)
Drug Safety, 45(12), 1501-1516. ADIS INT LTD
Drug Safety, 45(12), 1501. Springer International Publishing Switzerland
Drug Safety, Vol. 45, no. 12, p. 1501-1516 (2022)
Drug Safety, 45(12), 1501-1516. ADIS INT LTD
Drug Safety, 45(12), 1501. Springer International Publishing Switzerland
Introduction: Multimorbidity and polypharmacy are risk factors for drug-related hospital admissions (DRAs) in the ageing population. DRAs caused by medication errors (MEs) are considered potentially preventable. The STOPP/START criteria were develope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::672f3898b660657eeff946433fea2c39
https://boris.unibe.ch/174450/8/Sallevelt_DrugSaf_2022.pdf
https://boris.unibe.ch/174450/8/Sallevelt_DrugSaf_2022.pdf
The prevalence of multimorbidity and polypharmacy is increasing in the ageing population, and both are important risk factors for drug-related harm, such as drug-related hospital admissions. Previous studies have reported that 10%–30% of all hospit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10691::efbc4400e7d2b1c87bf2693ad97dbb3d
https://dspace.library.uu.nl/handle/1874/423649
https://dspace.library.uu.nl/handle/1874/423649
Autor:
Sallevelt, Bastiaan T. G. M.1,2 b.t.g.sallevelt@umcutrecht.nl, Teunis, Teun3, Agterof, Mariette J.4, Broek, Marcel P. H.1
Publikováno v:
Journal of Clinical Pharmacy & Therapeutics. Aug2020, Vol. 45 Issue 4, p832-835. 4p.
Autor:
Crowley, Erin K.1 (AUTHOR), Sallevelt, Bastiaan T. G. M.2 (AUTHOR), Huibers, Corlina J. A.3 (AUTHOR), Murphy, Kevin D.1 (AUTHOR) kevin.murphy@ucc.ie, Spruit, Marco4 (AUTHOR), Shen, Zhengru4 (AUTHOR), Boland, Benoît5,6 (AUTHOR), Spinewine, Anne7,8 (AUTHOR), Dalleur, Olivia7,9 (AUTHOR), Moutzouri, Elisavet10,11 (AUTHOR), Löwe, Axel10,11 (AUTHOR), Feller, Martin10,11 (AUTHOR), Schwab, Nathalie10 (AUTHOR), Adam, Luise10 (AUTHOR), Wilting, Ingeborg2 (AUTHOR), Knol, Wilma3 (AUTHOR), Rodondi, Nicolas10,11 (AUTHOR), Byrne, Stephen1 (AUTHOR), O'Mahony, Denis12,13 (AUTHOR)
Publikováno v:
BMC Health Services Research. 3/17/2020, Vol. 20 Issue 1, p1-12. 12p. 3 Charts.